01/14/2026
The Cardiac Cath Lab Team at Manhattan Specialists center implanted its first Omnia Secure MRI safe defibrillator lead this week. This is the first such implant in an Ambulatory Surgery Center in the US. The world’s smallest defibrillation lead (The OmniaSecure™️ MRI SureScan™️ by Medtronic Corporation ) was recently introduced. It is designed for pacing, sensing, cardioversion, and defibrillation therapies. This lead has demonstrated high defibrillation success, low complications, and reliable therapy delivery in the LEADR Global Pivotal Trial. It also has the potential to serve as a possible additional option for cardiac resynchronization by adopting the left bundle branch area (LBBA) pacing option. The small diameter and the improved flexibility are also likely to significantly reduce the risk of tricuspid regurgitation due to the lead crossing that valve.
Coupled with technological advances and improved safety of procedures, the delivery of quality cardiovascular care is rapidly undergoing a major transformation. These changes have enabled many of the cardiac procedures that once required overnight hospital stay to be safely performed in outpatient settings with same-day discharge. Ambulatory surgery centers (ASCs) have been shown to reduced costs both to the patient as well as the payors while providing excellent care with high patient satisfaction. A number of ASC s have stepped in to this changing paradigm to provide quality cardiovascular care with same day discharges. The ASC s now perform both coronary and peripheral stenting procedures as well as devices such as pacemaker implantation. The CMS recently announced extending Medicare reimbursement for cardiac catheter ablation to ASCs.
Manhattan Medical Group
